Some of the key players operating in the global medical cannabis market include Medical Marijuana Inc . , Aphria , Inc ., Aurora Cannabis , Inc ., MGC Pharmaceuticals Limited , Tilray , Medreleaf Corporation , BOL Pharma , Canopy Growth Corporation , Insys Therapeutics Inc . and GW Pharmaceuticals , plc .
Market Segmentation :
The medicinal cannabis market is segmented on the basis of point of sale , active ingredient , therapeutic application and geography . The point of sale segment is further bifurcated into dispensaries , online pharmacy and hospital pharmacy . On the basis of active ingredient , the market is classified into Tetrahydrocannabinol ( THC ) and Cannabidiol ( CBD ) whereas based on therapeutic application , the market is bifurcated into pain , arthritis , neurological disease neurological applications and other applications . Furthermore , neurological applications is segmented into epilepsy , multiple sclerosis and other neurological applications . Geographically , the market is divided into North America , Europe , Asia Pacific , Middle East and Africa and Latin America .
Obtain Report Details with technological advancement at https :// www . xpodenceresearch . com / Reports / Medicinal- Cannabis-Market
Region Analysis :
The North America region is expected to dominate the market over the forecast year owing to legalization of Marijuana in U . S . In the U . S ., manufacturers of Medicinal cannabis are focusing on expansion of their product business . For instance , in July 2016 , Insys Therapeutics , Inc . received the U . S . Food and Drug Administration ( FDA ) approval for dronabinol oral solution- Syndros , an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol is indicated to be used in the treatment of anorexia pertaining to AIDS and cancer chemotherapy-induced nausea and vomiting . Furthermore , in 2016 , Medical Marijuana , Inc . launched the HempMeds Mexico which is a CBD hemp oil product and the company intends to expand its cannabis business in the Latin America .
The market in Middle Easter and Africa region is estimated to grow during the forecast period . Among the GCC countries , Israel has approved the medical cannabis product . In Africa region , the governments in Lesotho and Malawi in South Africa have granted the license for medicinal marijuana in 2017 and Verve Dynamics , a Cape Town-based alternative medicines company has received a license from the government of Lesotho to cultivate the cannabidiol ( CBD ) medicinal cannabis .
Major Points from Table of content :
• Executive Summary
• Research Methodology
• Market Dynamics
• Industry Overview
• Global Medicinal Cannabis Market , By Product ( 2017-2025 )
• Global Medicinal Cannabis Market , By Regions ( 2017-2025 )
• Market Competition Analysis
About Us :
Xpodence Research have the most extensive collection of market research reports of many categories . Xpodence Research provides the best market research solution for every industry by publishing the best possible results of great market